FDA reviews new data on risks of erythropoiesis-stimulating agents [Archive]

View Full Version : FDA reviews new data on risks of erythropoiesis-stimulating agents

News

01-06-2008, 09:41 PM

The U.S. Food and Drug Administration (FDA) is reviewing new data from two studies that provide further evidence of the risks of anemia drugs known as erythropoiesis-stimulating agents, or ESAs.

More... (http://www.news-medical.net/?id=33954)